[Use and effect of simvastin in patients with type II diabetes].
Ten non insulin-dependent diabetics in satisfactory metabolic control but with high cholesterol levels were treated with simvastatin. A significant reduction of total cholesterol and LDL-cholesterol was obtained together with an increase in HDL-cholesterol, thus documenting the efficacy of this agent.
Camarda
G
G
Divisione di Medicina Generale, USL 29 di Caltagirone.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019821:Simvastatin; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin
Uso ed effetto della simvastatina in pazienti diabetici di tipo II.